BRIEF-NLS Pharmaceutics AG Agreed To Extend Merger Agreement Termination Date With Kadimastem From Aug 31 To Oct 31-March 2024-www.financetom.com

BRIEF-NLS Pharmaceutics AG Agreed To Extend Merger Agreement Termination Date With Kadimastem From Aug 31 To Oct 31

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-NLS Pharmaceutics AG Agreed To Extend Merger Agreement Termination Date With Kadimastem From Aug 31 To Oct 31

Aug 29, 2025 1:50 PM

Aug 29 (Reuters) - NLS Pharmaceutics AG ( NLSP ):

* NLS PHARMACEUTICS AG ( NLSP ): AGREED TO EXTEND MERGER AGREEMENT

TERMINATION DATE WITH KADIMASTEM FROM AUG 31 TO OCT 31- SEC

FILING

Further company coverage:

Previous page： Update: Market Chatter: Swiss Financial Regulator Intends to Block Investors Accessing Credit Suisse AT1 Files Next page： European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Market Chatter: Swiss Financial Regulator Intends to Block Investors Accessing Credit Suisse AT1 Files

Apr 4, 2024

11:05 AM EDT, 04/04/2024 (MT Newswires) -- (Updates with UBS response in the seventh paragraph.) Switzerland's financial regulator is seeking to block the release of certain documents to investors for not accessing Credit Suisse tier 1 bonds, the Financial Times reported Thursday, citing a letter from the Swiss Financial Market Supervisory Authority to the Swiss Federal Administrative Court last month....

European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading

Apr 4, 2024

11:06 AM EDT, 04/04/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher Thursday morning, rising 0.69% to 1,386.14 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by hotel booking site trivago (TRVG) and biopharmaceutical company Calliditas Therapeutics ( CALT ) , which rose 5.7% and 5.3%,...

Henry Schein Closes Acquisition of Majority Stake in TriMed

Apr 4, 2024

11:03 AM EDT, 04/04/2024 (MT Newswires) -- Henry Schein (HSIC) said Thursday it closed its acquisition of a majority stake in orthopedic company TriMed. Financial terms weren't disclosed. TriMed develops solutions for the orthopedic treatment of foot, ankle, hand and wrist. Henry Schein said it expects the acquisition to be neutral to 2024 non-GAAP per-share earnings and accretive afterwards. Price:...

Allarity Therapeutics to Implement 1-for-20 Reverse Stock Split

Apr 4, 2024

11:02 AM EDT, 04/04/2024 (MT Newswires) -- Allarity Therapeutics ( ALLR ) said Thursday it plans to implement a 1-for-20 reverse split of its common shares to regain compliance with Nasdaq's minimum bid price requirement. The company expects its shares to start trading on a split-adjusted basis Tuesday. Allarity Therapeutics ( ALLR ) shares were up 2.4% in recent Thursday...